TTY Biopharm Company Limited announced that Kao, Jung-Liang will be replaced with Chiang, Yung-Min, Senior Manager of Finance Department of Synmosa Biopharma Corporation, as internal audit officer, effective November 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
78.4 TWD | +0.51% | +1.03% | -2.49% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.49% | 601M | |
+30.38% | 684B | |
+29.72% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.49% | 240B | |
+9.60% | 208B | |
-7.24% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 4105 Stock
- News TTY Biopharm Company Limited
- TTY Biopharm Company Limited Announces Internal Audit Officer Changes, Effective November 7, 2022